drugset / Trial / NCT00913120
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to examine the superiority of YM150 to the placebo and to evaluate the dose-dependent response of YM150 in patients undergoing elective total hip replacement surgery.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | — | Other |
| Subject | darexaban | Small molecule | — | Oral |